Advertisement

Topics

Vertex’s CF drug gets label extension as pricing row continues

05:30 EST 23 Jan 2019 | pharmaphorum

While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug has received a label extension from the European Commission allowing it to be used in younger children. The Commission has approved the drug for th...

Original Article: Vertex’s CF drug gets label extension as pricing row continues

NEXT ARTICLE

More From BioPortfolio on "Vertex’s CF drug gets label extension as pricing row continues"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...